Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-005800-24-AT
EUCTR2008-005800-24-AT
Active, not recruiting
Not Applicable

Characterisation of humoral and cellular immunity of low- and high-responder after TBE vaccination

Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin0 sites84 target enrollmentSeptember 22, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsFSME-Immun®Inflexal®

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin
Enrollment
84
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2008
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin

Eligibility Criteria

Inclusion Criteria

  • •Adults (\=18 years) of both sexes without upper age limit
  • •Willingness to sign written informed consent form
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Age: \< 18 years
  • •Pregnancy or breast feeding
  • •prior TBE infection
  • •Acute infection at day of inclusion (day 0\) (body temperature \> 37\.9°C )
  • •Planned surgery within 2 weeks before/after any scheduled rabies vaccination during the entire study
  • •Concomitant medication: systemic cortisone, immune suppressive therapy 4 weeks before or planned medication during the study
  • •History of autoimmune disease
  • •drug addiction
  • •plasma donators
  • •administration of other vaccines 4 weeks before/after day 0

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot study
EUCTR2011-002928-41-ATMed. Uni. Wien, Klinik für Innere I52
Active, not recruiting
Phase 1
Detailed analysis of the immune responses after vaccination against Japanese Encephalitis in the elderly.
EUCTR2010-020450-33-ATInstitute of Specific Prophylaxis and Tropical Medicine60
Completed
Not Applicable
Investigation of the humoral and cellular immunity against SARS-CoV2 in patients after kidney transplantation in pandemic timesU07.1COVID-19, virus identified
DRKS00024171niversitätsklinikum Köln46
Recruiting
Phase 4
Evaluation of vaccine response to 13-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine in patients living with HIV/AIDS
RBR-3wshg2mHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Active, not recruiting
Not Applicable
A study of humoral and cellular-mediated immune response in Monoclonal gammopathy of Undetermined Significance after vaccination with trivalent inactivated influenza vaccine (influvac) - mgus-vacc respons
EUCTR2010-022693-14-NLuniversity medical centre groningen